Previous issue | Volume 89 | ESPE2018 | Next issue

57th Annual ESPE

Athens, Greece
27 Sep 2018 - 29 Sep 2018

Card image cap
ESPE 2018 57th European Society for Paediatric Endocrinology Annual Meeting 27-29 September 2018 Athens, Greece

Poster Presentations

GH & IGFs P3

Good Growth Response to Growth Hormone Therapy in Short Children with Normal Growth Hormone Secretion
aSidra Medicine, Doha, Qatar; bAlexandria University, Alexandria, Egypt; cHamad Medical Corporation, Doha, Qatar
hrp0089p3-p192
Growth Hormone Deficiency Intwo Children with Williams-Beuren Syndrome: The Long-Term Response to Growth Hormone (GH) Therapy
aUniversity of Alexandria Children Hospital, Alexandria, Qatar; bHamad Medical Center, Doha, Qatar
hrp0089p3-p193
Growth Hormone Treatment: Does Timing Matter?
aInstituto Português de Oncologia de Coimbra FG, EPE, Coimbra, Portugal; bCentro Hospitalar de Lisboa Central, EPE, Lisbon, Portugal; cCentro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal
hrp0089p3-p194
Adherence and Long-term Outcomes of Therapy in Pediatric Subjects in Greece Using Easypod™ Electromechanical Device for Growth Hormone Treatment: The Phase IV Multicentre Easypod™ Connect Observational Study (ECOS)
aNational and Kapodistrian University of Athens, Athens, Greece; bP. & A. Kyriakou Children’s Hospital, Athens, Greece; cMerck S.A, Athens, Greece; dMerck KGaA, Darmstadt, Germany
hrp0089p3-p197
Extremely Low Body Mass Index Negatively Impact the Response to Growth Hormone Treatment in Children with Growth Hormone Deficiency
aElias Hospital, Bucharest, Romania; bCarol Davila University of Medicine and Pharmacy, Bucharest, Romania
hrp0089p3-p199
Small for Gestational Age (SGA) Patients with Premature Treatment Discontinuation: Their Journey in French Real-life Settings
aHôpital des Enfants, CHU, Toulouse, France; bCHU, Angers, France; cCHRU - Université de Lorraine, Nancy, France; dHôpital Mère-Enfant - Groupement Hospitalier Est, Lyon, France; eNovo Nordisk, Paris, France
hrp0089p3-p200
Effects on Near-adult Height and Safety of Recombinant Human Growth Hormone in Growth Hormone Deficiency and Turner Syndrome Patients: Results from the LG Growth Study
aDepartment of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; bDepartment of Pediatrics, Konkuk University School of Medicine, Seoul, Republic of Korea; cDepartment of Pediatrics, Korea University College of Medicine, Ansan, Republic of Korea; dDepartment of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; eDepartment of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea; fDepartment of Pediatrics, College of Medicine, Dong-A University, Busan, Republic of Korea; gDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea; hDepartment of Pediatrics, College of Medicine, Hallym University, Seoul, Republic of Korea
hrp0089p3-p201
Final Adult Height After Growth Hormone Treatment in Patients with Turner Syndrome
aCollege of Medicine, Gachon University, Incheon, Republic of Korea; bYonsei University College of Medicine, Seoul, Republic of Korea
hrp0089p3-p202
Results of Mecasermin Treatment in Pediatric Patients Evaluated for Severe and Partial Primary Deficiency of IGF-1
Department of Pediatric Endocrinology, Diabetology with Cardiology Division, Medical University of Bialystok, Bialystok, Poland
hrp0089p3-p203
Small for Gestational Age (SGA) Patients in Real Life French Clinical Practice: What is the Difference Between Good and Poor Responders to GH Treatment
aHôpital Mère-Enfant - Groupement Hospitalier Est, Lyon, France; bCHU, Angers, France; cCHRU - Université de Lorraine, Nancy, France; dHôpital des Enfants, CHU, Toulouse, France; eNovo Nordisk, Paris, France
hrp0089p3-p205
Erythropoietin and Granulocyte Macrophage Colony Stimulating Factor Levels in Growth Hormone Deficient Children after 1 Year of Growth Hormone Therapy
aEndocrinology Research Centre, Moscow, Russian Federation; bM.V.Lomonosov Moscow State University, Moscow, Russian Federation
hrp0089p3-p207
Cost-effectiveness of Growth Hormone Therapy in Children in Russia
aEndocrinology Research Centre, Department of Paediatric Endocrinology, Moscow, Russian Federation; bMoscow State University of Medicine and Dentistry, Department of Public Health, Moscow, Russian Federation
hrp0089p3-p208
Vitamin D Status in Children with Isolated Idiopathic GH Deficiency (GHD) in North and Central Greece
aEndocrine Unit, 3rd Pediatric Department, Aristotle University of Thessaloniki, Hippokrateion Hospital of Thessaloniki, Thessaloniki, Greece; bFirst Department of Pediatrics, P. & A. Kyriakou Children’s Hospital, Athens, Greece
hrp0089p3-p209
A Pilot Study for Comparing Efficacy and Safety of the CinnaTropin® to the Reference Recombinant Human GH in Children with Isolated GH Deficiency and Multiple Pituitary Hormone Deficiency
aHazrat Aliasghar Children’s Hospital, Iran University of Medical Sciences, Tehran, Iran, Republic of Islamic; bMetabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran, Republic of Islamic; cChronic Diseases Research Center, Endocrinology and Metabolism Population Sciences, Tehran University of Medical Sciences, Tehran, Iran, Republic of Islamic; dSchool of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran, Republic of Islamic
hrp0089p3-p210
Study of the Effectiveness of GH in Children Born Small for Gestational Age in an Area of Northwestern Spain and its Associated Factors
aClinic University Hospital of Santiago de Compostela, USC, Santiago de Compostela, Spain; bÁlvaro Cunqueiro Hospital, Vigo, Spain; cClinic University Hospital of Coruña, A Coruña, Spain; dHospital Álvaro Cunqueiro, Vigo, Spain; eCinical University Lucus Augusti Hospital, Lugo, Spain
hrp0089p3-p211
Height Velocity and Height Gain in the First Year of GH Treatment: Predictive Factors of Good Statural Response in Small for Gestational Age (SGA) Patients
aCHU, Angers, France; bCHRU – Université de Lorraine, Nancy, France; cHôpital Mère-Enfant – Groupement Hospitalier Est, Lyon, France; dHôpital des Enfants, CHU, Toulouse, France; eNovo Nordisk, Paris, France
hrp0089p3-p212
Two Siblings with Short Stature
aSrinagesh Diabetes Thyroid and Endocrine Centre, Hyderabad, India; bCincinnati Children’s Hospital, Cincinnati, OH, USA; cSoumya Children’S Hospital, Hyderabad, India; dSri Venkateshwar Hospital, New Delhi, India; eInstitute of Child Health, Madras Medical College, Chennai, India
hrp0089p3-p214
Efficacy and Safety of Recombinant Human GH in Treating Chinese Children with Idiopathic Short Stature
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
hrp0089p3-p216
Comparison the Recombinant Human GH (rhGH) Treatment in Children with Idiopathic Short Stature (ISS) and GH Deficiency (GHD)
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
hrp0089p3-p217
Bone Age Maturation During the Three Years of GH Treatment in Patients with Idiopathic GH Deficiency and Idiopathic Short Stature: Analysis of Data from LG Growth Study
aDepartment of Pediatrics, Hallym University Medical Center, Hallym University College of Medicine, Seoul, Republic of Korea; bDepartment of Pediatrics, Chosun University School of Medicine, Gwangju, Republic of Korea
hrp0089p3-p218
Recombinant Growth Hormone Therapy in Prepubertal Children with Idiopathic Short Stature in Korea: A Phase III Randomized Trial
aDepartment of Pediatrics, Samsung Medical Center, Seoul, Republic of Korea bDepartment of Pediatrics, Hanyang University School of Medicine, Seoul, Republic of Korea. cDepartment of Pediatrics, Seoul St. Mary’s Hospital, Seoul, Republic of Korea. dDepartment of Pediatrics, The Catholic University of Korea, Seoul, Republic of Korea. eDepartment of Pediatrics, Kyungpook National University Hospital, Daegu, Republic of Korea. fDepartment of Pediatrics, Korea University Anam Hospital, Seoul, Republic of Korea. gDepartment of Pediatrics, Seoul National University Children’s Hospital, Seoul, Republic of Korea. hDepartment of Pediatrics, Ajou University Hospital, Suwon, Republic of Korea. iDepartment of Pediatrics, Onsei University Health Systerm, Seoul, Republic of Korea. jDepartment of Pediatrics, Severance Hospital, Seoul, Republic of Korea. kDepartment of Pediatrics, Inje University Busan Paik Hospital, Busan, Republic of Korea. lDepartment of Pediatrics, Chonnam National University Hospital, Gwangju, Republic of Korea. mDepartment of Pediatrics, Chungbuk National University Hospital, Cheongju, Republic of Korea. nData Management and Clinical Statistics Team, Dong-A ST Co,. LTD, Seoul, Republic of Korea. oDepartment of Pediatrics, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. pDepartment of Pediatrics, Medical Genetics Clinic and Laboratory, Asan Medical Center Children’s Hospital, Seoul, Republic of Korea. qDepartment of Pediatrics, University of Ulsan College of Medicine, Seoul, Republic of Korea
hrp0089p3-p398